| Term 
 
        | Describe the pathophysiology of Parkinson's Disease. |  | Definition 
 
        | 
Destruction of dopaminergic neurons in substantia nigra pars compactaDepletion of dopamine stores and degeneration nigrostriatal pathwayImbalance of Ach and D in corpus striatumImpairment of extrapyramidal tracts responsible for body movementsTremors, Rigidity, bradykinesia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Spherical intracytoplasmic aggregates in the remaining neurons of substantia nigra pars compacta |  | 
        |  | 
        
        | Term 
 
        | What part(s) of the brain can lewy bodies be found during preclinical phase of Parkinson's disease? |  | Definition 
 
        | medulla oblongata locus ceruleus raphe nuclei olfactory bulb |  | 
        |  | 
        
        | Term 
 
        | During the progression of Parkinson's disease, lewy bodies may ascend from the medulla oblongata, locus ceruleus, raphe nuclei and olfactory bulb to what? |  | Definition 
 
        | Midbrain (substantia nigra pars compacta) |  | 
        |  | 
        
        | Term 
 
        | In advanced cases of Parkinson's Disease, where can Lewy bodies be found?   What can this cause? |  | Definition 
 
        | Cortex;   behavioural and cognitive changes |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | jerky, stiff, variable rigidity affecting upper arms painful stiffness when walking |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | feeling of total muscle rigidity and inability to walk at initiation of movement |  | 
        |  | 
        
        | Term 
 
        | Other than tremor, rigidity, and bradykinesia, what other symptoms may be observed in Parkinson's patients? |  | Definition 
 
        | Postural instability Constipation Sweating Pain Speech/facial expression Poor sleep Fatigue Anxiety Depression |  | 
        |  | 
        
        | Term 
 
        | How is Parkinson's Disease diagnosed?   Progression monitored? |  | Definition 
 
        | Neurologic assessment Neuroimaging - MRI, PET (Positron Emision Tomography) -     needs to be validated Diagnose confirmed by response to therapy Progression monitored by using assessment scale (Unified Parkinson's Disease Rating Scale)   |  | 
        |  | 
        
        | Term 
 
        | Apart from carbidopa and benserazide, which drugs decrease the metabolism of levadopa? |  | Definition 
 
        | entacapone (COMT inhibitor)   selegiline (MAO-B inhibitor) |  | 
        |  | 
        
        | Term 
 
        | Name 6 dopamine agonists; 3 ergot, 3 non-ergot. |  | Definition 
 
        | Ergot: Bromocriptine, Cabergoline, Pergolide   Non ergot: Pramipexole, Ropinirole, Apomorphine |  | 
        |  | 
        
        | Term 
 
        | Which drugs may be used to treat 'wearing-off' symptoms of levadopa?     |  | Definition 
 
        | Selegiline   COMT inhibitors- entacapone, tolcapone     |  | 
        |  | 
        
        | Term 
 
        | What is the usual daily dose of levadopa? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What are counselling points associated with levadopa? |  | Definition 
 
        | Take on empty stomach, though if feeling GI discomfort, take with food.     |  | 
        |  | 
        
        | Term 
 
        | Which complications are associated with long-term therapy of Levadopa? |  | Definition 
 
        | movement fluctuations   dyskinesia |  | 
        |  | 
        
        | Term 
 
        | What are the side effects of dopamine agonists? |  | Definition 
 
        | nausea orthostatic hypertension lower extremity oedema |  | 
        |  | 
        
        | Term 
 
        | What are the side effects of Levadopa? |  | Definition 
 
        | GI: nausea, vomiting (treat with domperidone), constipation, dry mouth, peptic ulcers   CVS: orthostatic hypotension, syncope (fainting), dizziness, fatigue. Treat hypotension with more carbidopa; addition of fludrocortisone with salt; midodrine; or use of elastic stockings.   CNS: sedation, psychosis - reduce or stop amantadine, MAOIs and Anticholinergics stopped. Give clozapine or quetiapine   Motor: Fluctuations - end of dose wearing off, and also dykinesias: involuntary movements   |  | 
        |  | 
        
        | Term 
 
        | What drug may be used as a 'rescue therapy' for "off" episode inspite of optimal dose? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Nocturnal symptoms of parkinson's are relieved by what? |  | Definition 
 
        | Clonzepam, or   small doses of carbidopa/levadopa |  | 
        |  | 
        
        | Term 
 
        | How is entacapone and tolcapone categorised? MOA? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What is the normal dose for tolcapone? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What surgery may be done in treating Parkinson's disease? |  | Definition 
 
        | Chronic high frequency deep brain stimulation. |  | 
        |  | 
        
        | Term 
 
        | What are the side effects of anticholinergics? |  | Definition 
 
        | Dry mouth blurred vision dry eyes constipation urinary retention tachycardia memory loss |  | 
        |  | 
        
        | Term 
 
        | What anticholinergic drugs are used in the treatment of Parkinson's disease? |  | Definition 
 
        | benztropine trihexyphenidyl biperiden |  | 
        |  | 
        
        | Term 
 
        | What are the side effects of amantadine? |  | Definition 
 
        | confusion hyperexcitability insomnia dizziness orthostatic hypotension livedo reticularis (vascular cutaneous reaction with redish purple fish net mottling on extremeties)   |  | 
        |  |